Ethyl 3-(3,4-dichlorophenyl)-[1,2,4]oxadiazole-5-carboxylate, 95.0%, 1g

Barbituric acid, min. 99%, ultra pure, 500 g, plastic packaging.

Tideglusib, 98.0%, 5mg

Boc-L-Homoserine, 95.0%, 1g

5-bromo-1H-pyrazole-4-carbonitrile, 95%, 1g

6-Chloro-1-methyl-1H-imidazo[4,5-c]pyridine, 95.0%, 1g

((Oxybis(ethane-2,1-diyl))bis(oxy))bis(ethane-2,1-diyl) bis(4-methylbenzenesulfonate), 97.0%, 1g

(2S,4R)-1-((Benzyloxy)carbonyl)-4-((tert-butoxycarbonyl)amino)pyrrolidine-2-carboxylic acid, 98%, 5g

p-NN-Bis(2-chloroethyl)aminobenzaldehyde, 99%, 1g

TERT-BUTYL 3-OXO-4-(4-(TRIFLUOROMETHOXY)PHENYL) PIPERAZINE-1-CARBOXYLATE, 95.0%, 250mg

4,5-Dimethoxy-isatoic anhydride, 95.0%, 10g

1-(4-Bromophenyl)pyrrolidin-2-one, 95.0%, 250mg

5-CHLORO-1H-PYRROLO[3,2-B]PYRIDINE-2-CARBONITRILE, 95.0%, 100mg